A Brief Guide to the Practice of Radioimmunoscintigraphy and Radioimmunotherapy in Cancer

Epenetos A.A. , Britton K.E. , Mather S. Targetting of I-123 labelled tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 1982; ii: 999–1004.

Buraggi G.L. , Callegaro L. , Turrin A. Immunoscintigraphy with 123I, 99mTc and 111In-labelled F (ab’)2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen. J Nucl Med All Sci 1984; 28: 283–95.

Buraggi G.L. , Callegaro L. , Mariani G. Imaging with 131I-labelled monoclonal antibodies to a high molecular weight-melanoma associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab’) 2 fragments. Cancer Res 1985; 45: 3378–87.

Buraggi G.L. , Turrin A. , Cascinelli N. Immunoscintigraphy with antimelanoma monoclonal antibodies. In: Donato L. , Britton K.E. , ed. Immunoscintigraphy. Londo: Gordon & Breach, 1985; 215–53.

Fairweather D.S. , Bradwell A.R. , Dykes P.W. Improved tumour localisation using Indium-111 labelled antibodies. Brit Med J 1983; 287: 167–70.

Britton K.E. , Granowska M. Radioimmunoscintigraphy in tumour identification. Cancer Surveys 1987; 61: 247–67.

Bomanji J. , Hungerford J.L. , Granowska M. , Britton K.E. Radioimmunoscintigraphy of ocular melanoma with 99-Tc-m labelled cutaneous melanoma antibody fragments. Brit J Ophtalmol 1987; 71: 651–8.

Baum R.P. , Hertel A. , Lorenz M. , Schwarz A. , Encke A. , Hör G. ^99mTc-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy. First clinical results. Nucl Med Commun 1989 (in press).

Siccardi A.G. , Buraggi G.L. , Callegaro L. Multicentre study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res 1986; 46: 4817–22.

Granowska M. , Britton K.E. , Shepherd J.H. A prospective study of 123-I labelled monoclonal antibody imaging in ovarian cancer. J Clin Oncol 1986; 4: 730–6.

Schwarz A. , Steinstraesser A. A novel approach to Tc-99m labelled monoclonal antibodies. J Nucl Med 1987; 28: 721.

Wahl R.L. , Parker C.W. , Philpott G. Improved radio-imaging and tumour localisation with monoclonal (Fab 1’)2. J Nucl Med 1983; 24: 316–25.

Goldenberg D.M. , Kim E.E. , Deland F.H. , Benne H.S. , Primus F.J. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980; 40: 2984–92.

Granowska M. , Britton K.E. , Shepherd J. The detection of ovarian cancer using 123-I monoclonal antibody. Radiobiol Radiother (Berlin) 1983; 25: 153–60.

Granowska M. , Shepherd J. , Britton K.E. Ovarian cancer: diagnosis using 123-I monoclonal antibody in comparison with surgical findings. Nucl Med Commun 1984; 5: 485–99.

Granowska M. , Britton K.E. , Crowther M. Kinetic analysis with probability mapping in radioimmunoscintigraphy. In: Srivastava S.R. , ed. Radiolabelled monoclonal antibodies for imaging and therapy - potential, problems and prospects. Nato Advanced Science Institute, Barga. New York: Plenum Press, 1988; 311–22.

Granowska M. , Nimmon C.C. , Britton K.E. Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy. J Nucl Med 1988; 29: 599–607.

Begent R.H.J. , Keep P.A. , Green A.J. Liposomally entrapped second antibody improves tumour imaging with radiolabeled (first) anti-tumour antibody. Lancet 1983; 2: 739–41.

Kaplan E. , Ben-Porath M. , Fink S. , Clayton G.D. , Jacobson B. Elimination of liver interference from the selenomethionine pancreas scan. J Nucl Med 1966; 7: 807–9.

Ott R.J. , Grey L.J. , Zivanovic M.A. Limitations of dual radionuclide subtraction technique for detection of tumours by radioiodine labelled antibodies. Brit J Radiol 1983; 56: 101–8.

Green A.J. , Begent R.H.J. , Keep P.A. , Bagshawe K.D. Analysis of radioimmunodetection of tumours by the subtraction technique. J Nucl Med 1984; 25: 96–100.

Liehn J.C. Image subtraction techniques in immunoscintigraphy. In: Srivastava S.R. , ed. Radiolabeled monoclonal antibodies for imaging and therapy - potential, problems and prospects. NATO Advanced Science Institute, Barga 1986. New York: Plenum Press, 1988; 513–40.

Buell U. , Kessler M. , Scherer U. Diagnostik intrahepatischer Raumforderungen Leberszintigraphie, Sonographic und Transmissionscomputertomographie. Dtsch Med Wschr 1982; 107: 263–4.

Maublant J. , Cassagnes J. , LeJeune J.J. A comparison between conventional scintigraphy and emission tomography with thallium-201 in the detection of myocardial infarction. J Nucl Med 1982; 23: 204.

Holman B.L. , Hill T.C. , Magistretti P.L. Brain imaging with emission computed tomography and radiolabeled amines. Invest Radiol 1982; 17: 206.

Mueller St P. , Creutzig H. SPECT-physikalische und technisce Voraussetzungen. Nucl Med 1987; 26: 58–67.

Liehn J.C. , Hannequin P. , Nasea S. A new approach to image subtraction in immunoscintigraphy: preliminary results. Eur J Nucl Med 1987; 13: 391–6.

Berche C. , Mach J.P. , Lumbroso J.D. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabeled monoclonal antibodies against carcinoembryonic antigen. Brit Med J 1982; 285: 1447–51.

Delaloye B. , Bischof-Delaloye A. , Buchegger F. Detection of colorectal carcinoma by emission computerised tomography after injection of I-123 labelled Fab or (Fab’)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest 1986; 77: 301–11.

Bares R. , Fass J. , Truong S. , Buell U. , Schupelick V. Radioimmunoscintigraphy with SPECT: methods, problems and clinical experience. Nucl Med 1987; 26: 202–5.

Bares R. , Fass J. , Weiller G. Planar vs SPECT radioimmunoscintigraphy: clinical experience with Tc-99m, In-111 and 131-I labelled monoclonal antibodies against CEA and/or CA 19.9. Nucl Med 1987; 4: 24–5.

Bares R. , Fass J. , Buell U. , Schumpelick V. Validity of tomographical methods for radioimmunodetection of gastrointestinal tumours. In: Greten H. , Klapdor R. , eds. New tumour markers and their monoclonal antibodies - actual clinical relevance for diagnosis and therapy of solid tumours. Thieme, 1988; 470–4.

Hammersmith Oncology Group. Antibody guided irradiation of malignant disease. Lancet 1984; i: 1441–3.

Mather S.J. , Ward B. High efficiency iodination of monoclonal antibodies for radiolabelling. J Nucl Med 1987; 28: 1034–7.

Hnatowich D.J. , Virzi F. , Doherty P.W. DTPA-coupled antibodies labelled with Yttrium-90. J Nucl Med 1985; 25: 503–9.

Crowther M.E. , Britton K.E. , Granowska M. , Shepherd J.H. Monoclonal antibodies and their usefulness in epithelial ovarian cancer. Brit J Obs Gynaecol 1989 (in press).

Stewart J.S.W. , Hird V. , Sullivan M. , Snook D. , Epenetos A.A. Intraperitoneal radioimmunotherapy for ovarian cancer. Brit J Obs Gynaecol 1989 (in press).

Buraggi G.L. Tumor radioimmunodetection by anti-melanoma and anti-CEA monoclonal antibodies: pilot and prospective studies. In: Srivastava S.R. ed. Radiolabelled antibodies for imaging and therapy -potential problems and prospects. NATO Advanced Science Institute, Barga 1986, New York: Plenum Press 1988: 635–81.

Buraggi G.L. , Turrin A. , Bombardieri E. Immunoscintigraphy of colo-rectal carcinoma with F(ab’)2 fragments of anti-CEA monoclonal antibody. Cancer Det Prev 1987, 10: 335–45.

Gasparini M. , Ripamonti M. , seregni E. , Regalia E. , Buraggi G.L. Tumor imaging of colo-rectal carcinoma with an anti-CEA moonoclonal antibody. Int J Cancer suppl. 1988; 2: 81–84.

Buraggi G.L. , Turrin A. , Cascinelli N. Radioimmunodetection oof melanoma: preliminary results of a prospective study. Int J Biol Markers 1986, 1: 47–54.

Buraggi G. , Britton K.E. , Buell U. Joint Task Group on clinical utility of labelled antibodies. Int J Biol Markers 1986; 1: 147–53.